Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.
about
Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertilityProgestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancerControlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysisIVF and breast cancer: a systematic review and meta-analysisRisk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility.Female infertility, infertility-associated diagnoses, and comorbidities: a review.Fertility drugs, reproductive strategies and ovarian cancer risk.In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services.Female Reproductive Factors and Differentiated Thyroid Cancer.Female infertility.Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome).Fertility drugs and the risk of breast and gynecologic cancers.Preserving fertility in young patients with endometrial cancer: current perspectives.Fertility drug use and risk of ovarian tumors: a debated clinical challenge.Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort.Risk of breast cancer following fertility treatment--a registry based cohort study of parous women in Norway.Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2).Cancer risk among parous women following assisted reproductive technology.Effects of fertility drugs on cancers other than breast and gynecologic malignancies.Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort.Long-term relationship of ovulation-stimulating drugs to breast cancer risk.Does ovulation induction increase the risk of gynecological cancer?Long-term complications of assisted reproductive technologies.Breast cancer and fertility.Evidence-based lifestyle and pharmacological management of infertility in women with polycystic ovary syndrome.Breast cancer risk after exposure to fertility drugs.Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers.The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up.Cancer Risk in Women Treated with Fertility Drugs According to Parity Status-A Registry-based Cohort Study.Melanoma risk after ovarian stimulation for in vitro fertilization.State of the evidence 2017: an update on the connection between breast cancer and the environmentHormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer.Aromatase inhibitor use during ovarian stimulation suppresses growth of uterine endometrial cancer in xenograft mouse model.Long-term effects of repeated superovulation on the uterus and mammary gland in rhesus monkeys.Safety of clomiphene citrate: a literature review.Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study.
P2860
Q24200437-63534E0E-2594-4F30-AB91-A2A3E2EFB218Q28083257-2EDCC24B-99D4-4D92-BC21-0C9C9EC8D988Q28281796-26E863DE-896C-4424-8BEA-8947220B35B6Q28295207-A5EAFBA4-9F1B-4284-8AAA-CDB9F447F140Q30235061-21B05D18-8789-4849-ACD1-71A53AF8ED24Q30241736-4253540D-F9E2-414F-8174-2C44830F6EDDQ33608317-DFF943D9-04C2-43CB-8799-F829BF75AEEDQ33648309-17B30159-1520-4515-903B-8786BE50B174Q33715432-2C972587-15A9-4A13-9D09-AC1F49027F78Q33846768-02EF91F2-74D2-4491-85CB-DD596B60CB86Q33925579-E7C5054E-388B-4758-B434-BA121A046086Q33931378-ACEF82B8-F96F-4564-A85A-075A20BD8AE7Q34005400-91E91004-9659-413E-97AD-6AB1470C0FAEQ34297428-CAAB3FCE-7FE8-4DE6-8D37-F8C443431DFDQ34369162-9321DAA8-EC78-45B6-8A8C-9144EFF80E40Q34715540-88C0A9E2-CB66-4D78-BAB5-EE41955ABAEBQ35540547-F624523B-8AAF-49C1-AE6B-E14A8689EF83Q35678708-125AE3C0-1239-465B-954F-13D3DAD1657EQ35865978-EE3C54D5-5577-4C93-93F9-3FF9863EEB1CQ36119348-A1B4C0B6-B6AB-4FB1-B119-1316242FB32CQ37183938-24174D5E-6600-4FDC-B7B5-76A689446DD3Q37691958-45CE126A-6C81-4FB7-84EC-94A2A6ACD43CQ37703912-2C8E57DB-A748-408D-9853-57B8C84FB152Q37883367-5DDF55A1-5FF3-4C23-9489-138EB65FCACDQ37991254-217D0036-C956-49E4-AD5E-C006D8A71273Q38007200-550BD8E5-94FC-4418-8CFC-DA5E00E4F5C2Q38081240-5CFDC631-FF3E-4F53-8C90-842B408662A1Q38694178-76B6657C-665D-474E-97FC-D31FBD8871F2Q38967638-54663339-314A-4A45-BE01-D79D21E7D08AQ39008963-88BB6018-E39E-4105-B55F-45FCA594BB57Q41286527-13C209B1-21FC-4CE7-A194-EF49ADBD2D43Q41595188-5AF97150-7541-4929-8B08-8F09822857FDQ43427604-06F469DB-D0E4-4B91-A30D-E9A4CC157E13Q47180421-C6F0CF8A-9332-42A0-9D3F-B1DC0089A649Q47881572-A9B2D202-ADB7-4FCA-BD4F-274052CC31C1Q49844348-3B9CD383-1076-4114-908B-A43305529FC3Q50550240-24C22159-EB0A-4228-8355-7583A411AA91
P2860
Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.
@en
Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.
@nl
type
label
Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.
@en
Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.
@nl
prefLabel
Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.
@en
Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.
@nl
P2093
P2860
P356
P1476
Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort
@en
P2093
A B MacLean
I dos Santos Silva
P Hardiman
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605086
P407
P577
2009-05-12T00:00:00Z